TechInvest News

Magnis charged up by fast battery results - TechInvest Magazine Online

Written by Staff Writers | Jun 23, 2021 8:55:58 AM

Magnis Energy Technologies Limited (ASX: MNS) has revealed that significant fast charging battery results continue to be achieved using commercial optimised cells. The cells are developed by Magnis’s partner, Charge CCCV, LLC. (C4V). Magnis has a 9.65% stake in C4V.

Cycling results from an optimised commercial size cell to date using BMLMP technology have produced exciting results with cycling life retention of over 75% after 2,513 cycles with a 30- minute charge and 30-minute discharge.

The optimised cell is within 99% energy density of a regular energy cell, which means minimal energy density loss for an FC cell. Such high-power density without any Cobalt and Nickel for a Non-LFP cell makes C4V a leading company in the market, as they demonstrate cutting edge battery technologies.

Battery cells optimised for fast charging is required to maximise charging energy efficiency, battery life, and safety. Magnis’s technology partner, C4V, is at the forefront of this technology development and has been working with end-users including commercial EV manufacturers to develop a future proof design for EFC batteries, with a focus on low cost and a sustainable supply chain.

C4V President, Dr Shailesh Upreti, said the initial Extra Fast Charging six-minute results, while impressive, are too early to report, as only 100 cycles have been completed to date. In parallel variations are being made designed for minimum impedance and fastest charging. C4V has also placed an order for higher power test equipment and has started preparing for >20Ah cell construction, which would eventually be scaled to >50Ah prismatic cells to be used at iM3NY.

We are really excited by the ongoing results that we continue to achieve using this technology, and I believe this is one of the most exciting technologies currently in play for the transportation industry as well as certain parts of the Grid market. We look forward to providing further progressive results,” Dr Upreti said.

https://www.magnis.com.au/